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Abstract—Electrically active cells in the body produce a wide 
variety of voltage signals that are useful for medical diagnosis 
and scientific investigation.  These biopotentials span a wide 
range of amplitudes and frequencies.  We have developed a 
versatile front-end integrated circuit that can be used to amplify 
many types of bioelectrical signals.  The 0.6-µm CMOS chip 
contains 16 fully-differential amplifiers with gains of 46 dB, 
2µVrms input-referred noise, and bandwidths programmable 








 In all animals (and some plants [1]), information is 
transmitted and physical motion is initiated using both 
chemical and electrical signals.  Most electrically active cells 
can modulate their internal voltage by approximately 100 mV 
with respect to the extracellular fluid through the use of ion 
channels embedded in their membranes [2].  While 
intracellular recordings from single cells are possible for 
relatively brief periods of time if careful micropositioning 
equipment is used, the most practical methods for long-term 
biopotential recording observe cells from a distance. 
The most commonly observed biopotentials used in 
medical diagnoses can be monitored non-invasively with 
electrodes placed on the surface of the skin [3].  These include 
the electrocardiogram, or ECG (sometimes known by its 
German acronym as EKG), which monitors heart activity; the 
electromyogram (EMG) which monitors other muscle activity 
in the body; and the electroencephalolgram (EEG) which 
monitors electrical activity in the brain via weak potentials on 
the scalp. 
Implanted microwires or MEMS electrodes can observe 
biopotentials such as the EMG with greater fidelity.  
Implanted electrodes can also be placed in the brain to permit 
direct recording of individual neural action potentials, or 
“spikes” (e.g., [4], [5]).  In addition to monitoring the 
individual activity of a few nearby neurons, an electrode in the 
brain can observe low-frequency oscillations corresponding to 
the collective, synchronous activity of thousands of relatively 
distant neurons.  These signals, known as local field potentials 
(LFPs), are the internal correlate of the EEG signals observed 
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Fig. 1.  Approximate frequency content and amplitude distribution of common 
biopotentials recorded from the surface of the skin (white boxes) or internally 
(shaded boxes). 
 
Fig. 1 shows the approximate frequency content and 
amplitude distribution of common biopotentials of medical 
and scientific interest.  These signals span over four decades 
of frequency, from less than 1 Hz to around 10 kHz, and over 
four decades of amplitude, from 1 µV to over 10 mV. 
Traditionally, these weak electrical signals have been 
amplified, filtered, and conditioned using bulky rack-mounted 
equipment.  Recent advances in packaging, assembly, and 
integration have led to the development of small wearable and 
implantable medical and scientific instruments.  To advance 
device miniaturization, we have developed an integrated array 
of 16 fully-differential low-noise biopotential amplifiers with 
an on-chip analog multiplexer (MUX).  No off-chip capacitors 
are required to obtain low-frequency ac-coupled amplification, 
and two off-chip resistors allow the user to configure the 
amplifier bandwidth to optimize the recording of the 
biopotential signals shown in Fig. 1.  In Section II we describe 
the nature of the electrode-tissue interface, which is the source 
of our signals.  In Section III we introduce the amplifier 
circuits, and in Section IV we present experimental results 
from the fabricated chip including benchtop characterization 
as well as actual biopotential signals recorded using the chip.  
We conclude the paper in Section V. 
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Fig. 2.  Approximate small-signal model of biopotential recording site with 
differential measurement using a signal and reference electrode. 
 
 
II. THE ELECTRODE-TISSUE INTERFACE 
 
All biopotential recording systems require a physical 
interface between the metallic wires of the electronic circuits 
(where current is carried by electrons) and biological tissue 
(where current is carried by ions).  For ECG and EMG 
applications this interface usually takes the form of Ag/AgCl 
electrodes approximately 1-2 cm in diameter that adhere to the 
surface of the skin.  A thin layer of electrolyte-filled foam or 
gel separates the metal electrode from the skin, reducing 
artifacts caused by the relative movement of skin and 
electrode.  EEG recording systems often use Ag/AgCl 
electrodes held close to the head with a snug-fitting cap.  
Electrolyte gel is injected between each electrode and the 
scalp to provide a stable, conductive path through the hair.  It 
is also possible to record biopotentials from the skin using dry 
stainless steel electrodes, but these are more susceptible to 
movement artifacts. 
Implanted systems such as neural or intramuscular EMG 
recording devices typically use platinum or platinum-iridium 
electrodes constructed from fine wire or MEMS structures 
(e.g., [4], [5]).  The electrode is immersed in the extracellular 
fluid of the brain or muscle tissue and records the activity of 
nearby cells. 
In all electrode-tissue interfaces, an electrical double layer 
forms once equilibrium is reached.  For small voltage and 
current levels, this interface behaves primarily as a 
capacitance.  Textbook models of electrodes often include a 
resistance RP in parallel with the electrode capacitance CE, as 
well as a series resistance RS (see Fig. 2).  The contact 
between the metallic electrode and the electrolytic solution 
(i.e., gel or extracellular fluid) also produces a dc offset, 
shown as VOS in Fig. 2.  The sign and magnitude of this 
potential are functions of material properties, tissue condition, 
and temperature, and are difficult to predict.  Most external 
biopotential recording systems are designed to tolerate dc 
offsets of ±300 mV, and implanted electrodes can exhibit 
similar built-in potentials. 
We model the biopotential as an ac voltage source VSIG in 
series with a resistance RTISSUE that represents the conductive 
tissue between the signal and reference electrodes.  Although 
the equivalent circuit shown in Fig. 2 is a useful first-order 
model for low-voltage recording applications, it is important 
to realize that the actual electrode-tissue interface is a 
complex, nonlinear, time-variant structure that is difficult to 
model in any general or precise way.  The resistance and 
capacitance values in this model typically vary with frequency 
and signal amplitude. 
In external recording systems for ECG, EMG, or EEG, the 
signal and reference electrode are typically identical in size 
and structure; differential recording from two nearby points on 
the body is used to minimize pickup of 50/60-Hz power line 
interference.  (The in+ and in- terminals in Fig. 2 would be 
connected to the input of a differential amplifier.)  In addition 
to the differential recording electrodes, a third electrode is 
used to tie the body to circuit ground in order to guarantee a 
reasonable dc potential at the amplifier input.  The site of the 
ground electrode is usually chosen to be a part of the body 
with little electrical activity present (i.e., no nearby muscles).  
When EMG signals are recorded from the arm, the ground 
electrode is often attached to the bony tip of the elbow; EEG 
systems usually use ground leads attached to the earlobes. 
To provide an example of electrode properties in a typical 
biopotential recording situation, we characterized the 
impedance of Ag/AgCl conductive foam adhesive electrodes 
(Kendall-LTP, Chicopee, MA) positioned for EMG recording 
on the bicep approximately 5 cm apart.  At 1 kHz, we 
measured CE = 60 nF, RP = 210 k , RS = 7 , and RTISSUE = 
1.7 k .  Note that CE has an impedance magnitude much 
smaller than RP at this frequency, so RP has little effect and 
contributes little Johnson noise to the recording. 
Implantable microelectrodes have small surface areas and 
thus high impedances, so a low-impedance bare platinum wire 
a few centimeters in length is often used as a common 
reference electrode.  By convention, the impedance of 
microelectrodes used for neural recording is almost always 
reported as the magnitude of the impedance at 1 kHz.  For 
example, it is commonly reported in bioengineering and 
neuroscience literature that a “1 M  electrode” was used, for 
example.  The omitted details – that this is only the magnitude 
of the impedance (which almost always has a phase angle very 
near –90°) measured at 1 kHz – misleads many people new to 
the field into believing that the electrode has 1 M  of real 
resistance due to its small size.  This would indeed be an 
unfortunate situation for recording small neural signals since a 
1-M  resistor generates 13 µVrms of Johnson noise across a 
typical recording bandwidth of 10 kHz.  (In modern 
microelectrodes, the real series resistance RS is typically less 
than 10 k .)  Most microelectrodes used for neural recording 
have values of CE ranging from 0.16 nF to 16 nF (depending 
on electrode surface area and surface roughness), leading to 
commonly-cited electrode impedance magnitudes in the range 
of 10 k  – 1 M  at 1 kHz.  As with external electrodes, the 
value of RP is usually much greater than the impedance of CE 
at signal frequencies. 
One consequence of the complex, ill-defined nature of the 
electrode-tissue interface is that it is impossible to derive the 
noise figure (NF) of a biopotential amplifier since the concept 
of noise figure was developed for systems having a well-
defined source impedance (e.g., 50 ).  Instead, biopotential 
amplifiers are characterized by their input-referred noise 
measured across their bandwidth. 
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 Fig. 3. Schematic of operational transconductance amplifier (OTA) used in 
the first stage of the biopotential amplifier. 
 
III. CIRCUIT DESIGN 
 
In previous work, we developed a design technique to 
minimize the noise efficiency factor (NEF) and thus optimize 
the power-noise trade-off in biopotential amplifier design [6].  
Using drain currents (ID) in the high nanoampere or low 
microampere range, CMOS transistors can be operated either 
in strong inversion (above threshold), moderate inversion, or 
weak inversion (subthreshold) by appropriate sizing of their 
width-to-length ratio (W/L) [7], [8].  Using a current-mirror 
amplifier topology, the differential pair transistors are 
operated in weak inversion to maximize gm/ID, and the current 
mirror transistors are operated in strong inversion to minimize 
gm/ID.  In this paper we apply this method to a fully-
differential two-stage CMOS amplifier with a third-order 
Butterworth low-pass filter response. 
Fig. 3 shows a schematic of a fully-differential operational 
transconductance amplifier (OTA) used in the first stage of 
our biopotential amplifier.  The transconductance Gm of the 
amplifier is controlled by the bias current from transistor MB.  
The bias current can be varied from 20 nA to 40 µA by means 
of a bias generator circuit [9] that employs an off-chip resistor 
to select the current level and thus the OTA transconductance.  
The differential pair transistors M1-M2 are drawn wide (W/L > 
500) to maintain weak or moderate inversion operation.  The 
current mirror transistors M3-M6, as well as M7-M8, are drawn 
narrow (W/L < 1) to maintain strong or moderate inversion 
operation.  This design minimizes input-referred noise for a 
given bias current [6].  Cascode devices MC1-MC4 increase the 
output resistance of the OTA.  A common-mode feedback 
(CMFB) circuit maintains the dc level of the two output nodes 
halfway between VSS and VDD. 
Fig. 4 shows a schematic of the two-stage amplifier.  The 
first stage uses the fully-differential OTA from Fig. 3 in a 
differential amplifier configuration with capacitive feedback.  
The midband gain of the first stage is set by the capacitor ratio 
C1/C2, and is thus well controlled.  The high-frequency 
bandwidth of the first stage is set by Gm and the load 
capacitance CL.  Thus, by varying the bias current in the OTA, 



















Fig. 4.  Schematic of the complete two-stage biopotential amplifier. 
 
The input capacitors (C1) block dc electrode-tissue offset 
voltages.  The low-frequency cutoff fL is 1/2 RPRC2, where RPR 
is the equivalent small-signal resistance of the MOS-bipolar 
“pseudo-resistor” element MPR [6].  Extremely high values of 
RPR are obtained, yielding values of fL below 0.1 Hz.  While an 
amplifier response below 1 Hz is desirable in many 
biopotential recording applications (see Fig. 1), the long time 
constant associated with such a circuit leads to slow recovery 
from overloads or other large disturbances.  To address this 
problem, we added a “fast settle” function; when the MFS 
transistors are turned on by the digital, active-low FS signal, 
the amplifier output quickly returns to baseline. 
The second stage is a standard instrumentation amplifier 
topology with resistive feedback setting the gain to 1+2R2/R1.  
The unity-gain frequencies of the operational amplifiers in this 
stage are also controlled by adjustable bias currents, so their 
bandwidth may be programmed using a second off-chip 
resistor as part of a bias generator circuit.  The poles in these 
op amps are calibrated to yield a phase margin of 52° for the 
closed-loop gain set by R1 and R2.  This leads to a system 
having a second-order low-pass response with a quality factor 
Q = 1.  By setting the characteristic frequency 0 of the 
second stage equal to the –3 dB frequency of the first stage 
(which has a phase margin of close to 90° and thus behaves as 
a first-order system), we obtain a third-order Butterworth low-
pass filter with a maximally flat passband and a stopband roll-
off of –60 dB/decade.  By choosing appropriate values for the 
two off-chip resistors, we can align the cutoff frequencies to 
produce proper poles for a Butterworth filter. 
Fig. 5 shows a block diagram of the complete 16-channel 
amplifier chip.  An analog MUX controlled by the digital 
signals Select0 – Select3 allows all 16 amplifiers to share one 
analog-to-digital converter (not included on this chip).  The 
MUX includes fast unity-gain buffers to allow each channel to 
be sampled up to 30 kS/s.  Fully-differential design throughout 
the chip minimizes noise from common-mode interference. 
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Fig. 5.  Block diagram of 16-channel RHA1016 bioamplifier IC. 
 
IV. EXPERIMENTAL RESULTS 
 
A.  Benchtop Characterization 
We fabricated the 16-amplifier chip (designated 
RHA1016) in a 0.6-µm 2M2P CMOS process with linear 
metal-insulator-metal (MIM) capacitors.  The total silicon area 
used for circuitry and pads measured 4.2 × 2.8 mm2; the diced 
chip measured 4.3 × 3.1 mm2 (see Fig. 6).  Each amplifier 
channel, including analog MUX circuitry, consumed 0.37 
mm2.  The chip operates from a single +5V supply.  The only 
off-chip components required are the two resistors used to set 
the high-frequency bandwidth fH.  By varying the values of 
these two resistors, fH can be programmed to any frequency 
from 10 Hz to 10 kHz. 
As shown in Fig. 5, the total gain of each two-stage 
amplifier was set to 200 V/V (46 dB) with appropriate 
capacitor and resistor ratios; this gain was confirmed by 
measurement.  Fig. 7 shows the measured normalized gain 
(i.e., with the midband gain of 46 dB subtracted) of one 
amplifier with fH set to 1 kHz.  The 3
rd-order Butterworth low-
pass response of the amplifier is evident, with a flat passband, 
the –3dB drop in gain at 1 kHz, and a –60 dB drop precisely 
one decade higher at 10 kHz.  The phase response of the same 
amplifier is shown in Fig. 8.  The three-pole low-pass filter 
leads to 270° of phase lag deep in the stopband. 
The input-referred noise of the two-stage amplifier was 
measured by grounding the inputs, measuring the output noise 
using a sensitive low-noise preamplifier (Stanford Research 
Systems SR560) connected to an oscilloscope and low-
frequency spectrum analyzer (Stanford Research Systems 
SR770), and dividing by the amplifier gain of 200 V/V.  Fig. 9 
shows the input-referred noise of an amplifier with fH set to 10 
kHz; Fig. 10 shows the input-referred noise for the same 
amplifer set to fH = 100 Hz.  In both cases, the input-referred 
noise is 2 µVrms since the reduction in bandwidth is balanced 
by the increase in thermal noise due to lower bias currents. 
 
Fig. 6.  Die photo of the 16-channel bioamplifier integrated circuit.  The chip 





Fig. 7.  Measured normalized gain vs. frequency for fH = 1 kHz. 
 
 
Fig. 8.  Measured phase lag vs. frequency for fH = 1 kHz. 
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Fig. 11 shows the measured input-referred noise spectra 
for amplifiers with fH set to 10 Hz, 100 Hz, 1 kHz, and 10 
kHz.  The higher thermal noise levels with lower bandwidths 
are evident in the data.  Notice that due to the relatively high 
thermal noise levels (and the use of large gate area pMOS 
devices in the input differential pair) 1/f noise only dominates 
at frequencies less than approximately 0.1fH.  Thus, flicker 
noise does not dominate the total rms input-referred noise, 
which stays nearly constant at 2 µVrms across all values of fH. 
We measured the common-mode rejection ratio (CMRR) 
for 48 amplifiers across three chips, testing at frequencies of 
60 Hz and 1 kHz.  At both frequencies, the average CMRR 
was 84 dB.  Observed CMRR values ranged from 71 dB to 
101 dB.  Power-supply rejection ratio (PSRR) was also 
measured across these 48 amplifiers at 60 Hz and 1 kHz.  At 
both frequencies, the average PSRR was 75 dB.  Observed 
PSRR values ranged from 66 dB to 92 dB.  Input-referred 
voltage offset was measured across 96 amplifiers on six chips.  
Input-referred offset was symmetrically distributed about zero 
with a standard deviation of 170 µV.  The largest observed 
offsets were ±430 µV. 
 
B.  Biopotential Measurements 
After benchtop characterization was completed, we used 
the RHA1016 integrated circuit to amplify real biopotentials 
obtained using commercially available electrodes.  We used 
adhesive Ag/AgCl electrodes to obtain human ECG and EMG 
signals (see Figs. 12 and 13).  In both cases, the differential 
recording electrodes were positioned approximately 5 cm 
apart, with the amplifier ground connected to an Ag/AgCl 
electrode on the elbow.  For ECG recordings, the amplifier 
was configured to have a bandwidth of 100 Hz; for EMG 
recordings, the bandwidth was set to 1 kHz. 
Human EEG recordings were obtained using Ag/AgCl 
electrodes filled with electrolyte gel on an elastic cap, with 
amplifier ground connected to the left earlobe.  Fig. 14 shows 
10-Hz, 60-µVpp alpha waves recorded from the occipital 
region in the back of the head (over primary visual cortex) 
from standard electrode positions O1-O2 [10] with the 
amplifier bandwidth set to 50 Hz.  The subject’s eyes were 
closed initially, then opened at t = 0, suppressing the alpha 
waves.  (Alpha waves in the 10-Hz range commonly appear in 
the occipital region when the eyes are closed.)  Fig. 15 shows 
a human EEG signal recorded from frontal region Fp1-F3 on 
the forehead.  Two eye-blink artifacts (commonly observed in 
this region of the head) are visible. 
Neural recordings were obtained using a MEMS 100-
microelectrode array (Cyberkinetics, Inc., Foxborough, MA) 
implanted in the motor cortex of a cat.  The recordings were 
performed approximately three months after implantation.  A 
platinum wire implanted near the array was used for the 
reference signal, and the amplifier ground was connected to a 
small metal pedestal on the cat’s head that served as a 
connector to the electrode array and reference wire.  The cat 
was awake and comfortably resting during the measurements. 
 
 
Fig. 9.  Measured input-referred noise for fH = 10 kHz. 
 
 
Fig. 10.  Measured input-referred noise for fH = 100 Hz. 
 
 
Fig. 11.  Input-referred noise spectra for fH = 10 Hz (dot), fH = 100 Hz (dash-
dot), fH = 1 kHz (dash), and fH = 10 kHz (solid). 
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 Fig. 12.  ECG signal recorded with Ag/AgCl electrodes on the chest 




Fig. 13.  EMG signal recorded with Ag/AgCl electrodes over bicep during two 




Fig. 14.  EEG signal with 10-Hz alpha waves recorded from occipital region 
O1-O2 (fH = 50 Hz).  Subject’s eyes were closed initially, then opened at t = 0, 
suppressing the alpha waves. 
 
Fig. 15.  EEG signal recorded from frontal region Fp1-F3 on the forehead (fH = 
50 Hz).  Two eye-blink artifacts (commonly observed in this region of the 
head) are visible. 
 
 
Fig. 16.  Neural recording from motor cortex of cat with MEMS electrode 
array showing both spikes and LFPs (fH = 5 kHz). 
 
 
Fig. 17.  Data from Fig. 16 after a 300-Hz one-pole high-pass filter was 
applied in software to remove LFPs and preserve spikes. 
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Fig. 18.  Large and small spikes observed in motor cortex of cat.  (A one-pole 
high-pass filter at 300 Hz was applied to the signal.) 
 
Fig. 16 shows a 200-ms segment of spontaneous neural 
activity recorded using an amplifier with fH = 5 kHz.  Both 
low-frequency local field potentials (LFPs) and high-
frequency neural spikes are observed.  This data was digitally 
high-pass filtered to attenuate signals below 300 Hz (see Fig. 
17).  This eliminates the LFP signals while preserving the 
spikes.  Fig. 18 shows another neural waveform that was high-
pass filtered at 300 Hz.  Here, both large- and small-amplitude 
spikes (presumably originating from two distinct neurons) can 
be observed.  In Fig. 19, several neural spikes are aligned 
based on the time they crossed a user-defined threshold.  This 
plot demonstrates that 2-3 distinct neurons with consistent 
waveforms are being observed. 
Fig. 20 demonstrates the ability of the amplifier to observe 
trends in the low-frequency LFP signals over this seven-
second span.  Around t = 2.5 s, strong beta-wave activity in 
the 10-15 Hz range appears.  This activity can be seen clearly 
in a spectrogram of the data presented in Fig. 21.  Although it 
is difficult to see in Fig. 20 due to the extended time scale, this 
data contains both spikes and LFPs that are easily separated 
with simple digital post-processing. 
Finally, to demonstrate the ability of the amplifier to 
record very-low-frequency signals, we recorded an action 
potential from the Venus flytrap plant (Dionaea muscipula) 
using Ag/AgCl electrodes placed on either side of a trap, with 
amplifier ground tied to the soil (see Fig. 22).  The amplifier 
was configured to have a bandwidth of 50 Hz.  When a trigger 
hair inside the trap was bent, an action potential lasting several 
seconds was produced [1].  (This isolated stimulus did not 
cause closure of the trap, so no movement artifacts are present 




 The measured characteristics of the integrated biopotential 
amplifier chip are summarized in Table I.  The total power 
dissipation of the chip depends on the desired amplifier 
  
 
Fig. 19.  Several time-aligned spikes from motor cortex of cat. 
 
 
Fig. 20.  Seven-second neural recording from motor cortex of cat showing 
onset of 10-15 Hz beta activity in the local field potential. 
 
 
Fig. 21.  Spectrogram of neural data from Fig. 20. 
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 Fig. 22.  Action potential measured from Venus flytrap (Dionaea muscipula) 
during bending of trigger hair (fH = 50 Hz). 
 
 
bandwidth.  For fH = 10 kHz, the chip consumes 41 mW.  For 
bandwidths of 1 kHz or less the chip consumes 28 mW, as 
total power dissipation is dominated by the fast buffers in the 
analog MUX that provide a settling time of less than 1 µs.  At 
a bandwidth of 1 kHz, the power consumption of a single two-
stage amplifier shown in Fig. 4 is 460 µW. 
The amplifier presented here is designed to pass signals 
from less than 0.1 Hz up to a user-specified high-frequency 
cutoff.  In addition to attenuating high-frequency noise, the 
3rd-order lowpass filter at fH acts as a built-in anti-aliasing 
filter and permits low-frequency signals such as EEGs or 
ECGs to be digitized at a slower rate than higher-frequency 
signals such as neural spikes.  For highly parallel recording 
systems with large numbers of channels, it makes sense to 
limit the sampling frequency to minimize the rate at which 
data must be stored or transmitted.  In wideband recordings, 
undesired low-frequency signals (e.g., LFPs) can be easily 
filtered out digitally after digitization. 
 Although the bandwidth of this amplifier is variable, the 
gain is fixed at 200 V/V.  A variable-gain architecture was 
considered, but modern high-quality analog-to-digital 
converters (ADCs) diminish the need for this degree of 
control.  To illustrate this claim, consider that the amplifier 
input-referred noise of 2 µVrms produces a 400 µVrms noise 
signal at the output.  A 16-bit ADC operating across 5 V can 
resolve steps of 76µV, so increasing the gain beyond 200 
accomplishes little at the system level. 
 This chip might benefit somewhat from fabrication in a 
smaller process, though much of the silicon area is consumed 
by linear capacitors (~1 fF/µm2) which do not scale greatly in 
deep submicron processes.  Alternately, die area could be 
reduced by trading off increased input-referred noise levels for 








MEASURED AMPLIFIER PERFORMANCE 
Parameter Measured Value Comments 
















filter roll-of above fH 
Temperature coefficient 
of fH 
+0.4 %/°C  
CMRR 71 dB – 101 dB 
mean CMRR: 84 dB 
measured at 60 Hz and 
1 kHz with fH = 10 kHz 
PSRR 66 dB – 92 dB 
mean PSRR: 75 dB 
measured at 60 Hz and 
1 kHz with fH = 10 kHz 
Crosstalk 
 
< –90 dB 
(0.05 Hz to 10 kHz) 
measured between 
adjacent amplifiers 
Input offset voltage 
 
< ±0.6 mV Input offset varies 
–1.0 µV/°C with temp. 
Input bias current 
 




2 µVrms  
Total harmonic distortion 2 mVpp input: 0.1% 
10 mVpp input: <1% 
f = 1 kHz, fH = 10 kHz 
Dynamic range 
 
65 dB  
MUX settling time 
 
< 1.0 µs allows sampling at 
30 kHz per channel 
Total 16-amplifier chip 
power dissipation 
28 mW (fH = 1 kHz) 
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